{"id":58933,"date":"2022-01-25T17:12:00","date_gmt":"2022-01-25T13:12:00","guid":{"rendered":"https:\/\/noortrends.ae\/en\/?p=58933"},"modified":"2022-01-25T18:04:23","modified_gmt":"2022-01-25T14:04:23","slug":"pfizer-and-biotech-launch-a-trial-of-a-vaccine-targeting-omicron","status":"publish","type":"post","link":"https:\/\/noortrends.ae\/en\/pfizer-and-biotech-launch-a-trial-of-a-vaccine-targeting-omicron\/01\/25\/market-updates\/","title":{"rendered":"Pfizer and Biotech launch a trial of a vaccine targeting Omicron"},"content":{"rendered":"\n<p>Pfizer and Biotech said Tuesday they have started a clinical trial to test a new version of their vaccine specifically designed to target the omicron mutant of COVID-19 that has eluded some of the protection provided by the original two-dose vaccine regimen.<\/p>\n\n\n\n<p>The two companies intend to test the immune response from the Omicron vaccine as a three-dose regimen for unvaccinated people and as a booster dose for those who received two doses of the company&#8217;s original vaccine.<\/p>\n\n\n\n<p>The two companies are also testing a fourth dose of the current vaccine compared to a fourth dose of the Omicron vaccine in people who received their third dose of the Pfizer\/Biontech vaccine between three and six months ago.<\/p>\n\n\n\n<p>The two companies plan to study the safety and tolerability of the vaccines in the more than 1,400 people who will participate in the trial.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer and Biotech said Tuesday they have started a clinical trial to test a new version of their vaccine specifically designed to target the omicron mutant of COVID-19 that has eluded some of the protection provided by the original two-dose vaccine regimen. The two companies intend to test the immune response from the Omicron vaccine &hellip;<\/p>\n","protected":false},"author":9,"featured_media":48869,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[39,36],"tags":[8166,7410,6879,8236],"class_list":["post-58933","post","type-post","status-publish","format-standard","has-post-thumbnail","","category-global-stock-markets","category-market-updates","tag-omicron","tag-pfizer","tag-shares","tag-vaccines"],"_links":{"self":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts\/58933","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/comments?post=58933"}],"version-history":[{"count":1,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts\/58933\/revisions"}],"predecessor-version":[{"id":58934,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts\/58933\/revisions\/58934"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/media\/48869"}],"wp:attachment":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/media?parent=58933"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/categories?post=58933"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/tags?post=58933"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}